Royalty Pharma RPRX Price / book
Price / book at other companies
Other financials
Where this comes from
Calculated from Royalty Pharma’s reported figures.
Based on the most recent quarter.
The official record: Royalty Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Royalty Pharma's price / book.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Royalty Pharma's price / book?
- Royalty Pharma (RPRX) reported price / book of 2.1× in Q1 2026.
- How has Royalty Pharma's price / book changed year-over-year?
- Royalty Pharma's price / book increased by 49.9% year-over-year, from 1.4× to 2.1×.
- What is the long-term trend for Royalty Pharma's price / book?
- Over 4 years (2021 to 2025), Royalty Pharma's price / book has grown at a -1.9% compound annual growth rate (CAGR), from 6.8× to 6.3×.
- What does price / book mean?
- How the market price compares to the company's accounting net worth.
- How do you interpret price / book?
- Below 1.0 can flag a market discount to book value (common for distressed or asset-heavy firms); high values reflect intangible value the balance sheet doesn't capture. Most informative for financials and asset-heavy businesses.
- How does price / book compare across companies?
- A core valuation gauge for banks and insurers; weak for asset-light firms where book value understates economic value.